To examine the relationship between vascular calcification in the foot (FVC) and bone mineral density (BMD) in the heel of type 2 diabetes mellitus (DM) subjects.
65 subjects with type 2 DM and serum creatinine < 125 μmol/l underwent CT scanning of the foot to assess FVC and dual energy X ray absorptiometry (DEXA) scan to assess heel BMD. Routine biochemistry including osteoprotegerin (OPG) and Receptor activator of nuclear factor kappa-B ligand (RANKL) was also carried out.
The proportion of subjects with FVC was 43%, whilst 40% had low BMD (T score < −1.0). Age, neuropathy and 25 hydroxyvitamin D were independent predictors of FVC. Body-weight, eGFR, 25 hydroxyvitamin D, OPG, and total cholesterol were independent predictors of low heel BMD. There was no correlation between albuminuria and BMD or FVC. There was no difference in heel BMD between those with FVC and those without, but those with frank osteoporosis were significantly more likely to have FVC than those with higher BMD.
There is no clear-cut association between FVC and low BMD in type 2 DM with relatively well-preserved renal function. Age, neuropathy, eGFR, hyperlipidemia, body-weight, 25 hydroxyvitamin D and OPG play a complex role in their pathogenesis.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Diabetes Research and Clinical Practice
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The epidemiology of lower extremity amputations in diabetic individuals.Diabetes Care. 1983; 6: 87-91
- A study of the lower extremities in diabetes as compared with non-diabetic states from the standpoint of X-ray findings, with particular reference to the relationship of arteriosclerosis and diabetes.Bull Buffalo Gen Hosp. 1924; 2: 35-41
- Osteopenia and metatarsal fractures in diabetic neuropathy.Diabet Med. 1985; 2: 461-464
- Bone mineral density in patients with type 1 and type 2 diabetes.Diabetes Care. 1999; 22: 1196-1200
- Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels.Osteoporos Int. 2004; 15: 389-395
- Vascular calcification and osteolysis in diabetic neuropathy—is RANK-L the missing link?.Diabetologia. 2004; 47: 1488-1492
- RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.Arterioscler Thromb Vasc Biol. 2002; 22: 549-553
- Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists.Diabetes Care. 2008; 31: 1679-1685
- Quantification of coronary artery calcium using ultrafast computed tomography.J Am Coll Cardiol. 1990; 15: 827-832
- A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.Ann Intern Med. 1999; 130: 461-470
- Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes.Nephrol Dial Transplant. 2007; 22: 3208-3213
- Lower-extremity arterial calcification as a correlate of coronary artery calcification.Metabolism. 2006; 55: 1689-1696
- Medial arterial calcification and diabetic neuropathy.Br Med J (Clin Res Ed). 1982; 284: 928-930
- Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects.Diabetologia. 1993; 36: 615-621
- Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.Diab Med. 2005; 22: 756-761
- Foot bone mass and analysis of calcium metabolism in diabetic patients affected by severe neuropathy.Minerva Endocrinol. 2008; 33: 283-288
- A study of bone mineral density in diabetes mellitus in eastern India.J Indian Med Assoc. 2004; 102 (418, 420, 422)
- Differential effects of vitamin D analogs on vascular calcification.J Bone Miner Res. 2007; 22: 860-866
- Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency.J Am Soc Nephrol. 2007; 18: 613-620
- Vitamin D and osteogenic differentiation in the artery wall.Clin J Am Soc Nephrol. 2008; 3: 1542-1547
- Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men.J Clin Endocrinol Metab. 2008; 93: 40-46
- Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(−/−) mice.Circulation. 2008; 117: 411-420
- Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Monckeberg's sclerosis and atherosclerosis.J Clin Endocrinol Metab. 2004; 89: 4104-4112
- Increased osteoprotegerin serum levels in men with coronary artery disease.J Clin Endocrinol Metab. 2003; 88: 1024-1028
- Medial arterial calcification is frequently found in patients with microalbuminuria.Angiology. 1999; 50: 971-975
- Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes.J Diabet Complications. 2009; 23: 12-17
- Reduced plasma pyrophosphate levels in hemodialysis patients.J Am Soc Nephrol. 2005; 16: 2495-2500
Published online: September 05, 2011
Accepted: August 1, 2011
Received in revised form: July 27, 2011
Received: March 24, 2011
© 2011 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.